PUBLISHER: BIS Research | PRODUCT CODE: 1269570
PUBLISHER: BIS Research | PRODUCT CODE: 1269570
Global Organ Transplant Diagnostics Market to Reach $11.78 Billion by 2033
Global Organ Transplant Diagnostics Market: Industry Overview
In 2022, the global organ transplant diagnostics market was valued at $4.03 billion and is expected to reach $11.78 billion by 2033, with a CAGR of 10.45% during the forecast period 2023-2033. The key factors driving growth include a rise in the incidence of chronic diseases leading to organ failure increases in the use of transplant diagnostics, increase in the adoption of stem cell therapy and incidences of leukemia leading to an upsurge in demand for transplant diagnostics tests, advantages of developing advanced molecular and genomic technologies in the transplant diagnostics, and presence of favorable regulatory scenario including reimbursement schemes.
Market Lifecycle Stage
The global organ transplant diagnostics market is in the developed phase. The development of non-invasive techniques for monitoring transplant recipients using NGS and advancements in human leukocyte antigen (HLA) typing tests for an organ transplant are some of the major opportunities in the global organ transplant diagnostics market.
Impact of COVID-19
The COVID-19 pandemic impacted the healthcare segment in different ways. The organ transplant segment of the industry got highly impacted by the pandemic, as the focus of hospitals and ambulatory centers shifted toward the affected patients. Moreover, as a method of prevention, surgeries got delayed, which had a significant effect on organ transplant procedures and on organ transplant diagnostics tests.
Market Segmentation:
Segmentation 1: by Offering
The global organ transplant diagnostics market (by offering) is expected to be dominated by the services segment.
Segmentation 2: by Transplant Type
The global organ transplant diagnostics market (by transplant type) is expected to be dominated by the solid organ transplant segment.
Segmentation 3: by Application
The global organ transplant diagnostics market (by application) is expected to be dominated by the diagnostics segment.
Segmentation 4: by Technology
The global organ transplant diagnostics market (by technology) is expected to be dominated by the molecular technologies segment.
Segmentation 5: by End User
The global organ transplant diagnostics market (by end user) is expected to be dominated by the hospitals and transplant centers segment.
Segmentation 6: by Region
The global organ transplant diagnostics market (by region) is dominated by the North America region.
Recent Developments in the Global Organ Transplant Diagnostics Market
Demand - Drivers and Limitations
Following are the drivers for the Global Organ Transplant Diagnostics market:
The market is expected to face some limitations as well due to the following challenges:
How can this report add value to an organization?
Offerings: The offerings segment helps the reader understand the different manufacturers and service providers available in the market for organ transplant diagnostics. Moreover, the study provides the reader with a detailed understanding of transplant types and applications.
Growth/Marketing Strategy: The global organ transplant diagnostics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been synergistic activities such as partnerships, collaborations, expansions, and funding activities. For instance, in April 2023, bioMerieux S.A. and Oxford Nanopore entered into a strategic partnership agreement to develop innovative infectious disease diagnostics, which will also lead to the development of infectious disease tests used during transplantation.
Competitive Strategy: The key players in the global organ transplant diagnostics market analyzed and profiled in the study involve established and emerging players that offer different products and services for organ transplant diagnostics. Moreover, a detailed competitive benchmarking of the players operating in the global organ transplant diagnostics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Key Companies Profiled
Manufacturers
Service Providers